Akron Formulations India Private Limited, a active private limited company, was established on 05 August 1985 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239TG1985PTC005701. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹14.00 Cr and a paid-up capital of ₹13.98 Cr.
Formerly known as Hightech Pharmaceuticals Pvt Ltd. It upholds a compliant status. Employing 91 professional, Its leadership includes Kumaraswamy Reddy Maruri (Director), Maruri Leelavathi (Director), Satyanarayana Reddy (Director). Past directors included Penumatsa Sarala Devi, Sulochana Srinivasan, Umadevi Chava. It holds ₹39.01 Cr open charges and ₹34.92 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at #134-B, Ida Bollaram Jinnaram Mandal, Hyderabad, Telangana, 502325.
U24239TG1985PTC005701
005701
05 August 1985
₹14.00 Cr
₹13.98 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Akron Formulations India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kumaraswamy Reddy Maruri | Director | 27 Feb 2023 | Current |
| Maruri Leelavathi | Director | 12 Mar 2024 | Current |
| Satyanarayana Reddy | Director | 27 Feb 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Aug 2021 | Past |
| Pramod Abcsdd | Director | 08 Sep 2012 | Past |
| Pramod Abcsdd | Additional Director | 03 Nov 2022 | Past |
| Pramod Abcsdd | Director | 03 Nov 2022 | Past |
| Pramod Abcsdd | Director | 31 Mar 2023 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Akron Formulations India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 44.56% decrease. The company also saw a substantial fall in profitability, with a 92.67% decrease in profit. The company's net worth moved up by a moderate rise of 0.67%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Akron Formulations India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹390,100,000.00
₹349,156,250.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Dec 2025 | Indian Bank | ₹14.01 Cr | Open |
| 10 Jul 2014 | Axis Bank Limited | ₹25.00 Cr | Open |
| 27 May 2021 | Sidbi | ₹2.00 Cr | Satisfied |
| 26 Nov 2020 | Sidbi | ₹2.52 Cr | Satisfied |
| 29 Jul 2019 | Hdfc Bank Limited | ₹7.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Akron Formulations India has a workforce of 91 employees as of Apr 04, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Akron Formulations India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akron Formulations India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Indian Bank amounted to Rs. 14.01 Cr with Charge ID 101203451 was registered on 01 Dec 2025. was recorded as a recent event.
Akron Formulations India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Akron Formulations India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.
The activity A charge with Axis Bank Limited of Rs. 25.00 Cr registered on 10 Jul 2014 with Charge ID 10509274 was modified on 30 Sep 2024. was completed.
Progress on Maruri Leelavathi was appointed as a Director was appointed as a Director on 12 Mar 2024 & has been associated with this company since 1 year 9 months . was documented.
The activity Kapil Mundhada was appointed as a Company Secretary was appointed as a Company Secretary on 06 Mar 2024 & has been associated with this company since 1 year 10 months . was completed.
The CIN of Akron Formulations India Private Limited is U24239TG1985PTC005701.
Akron Formulations India Private Limited is headquartered at #134-B, Ida Bollaram Jinnaram Mandal, Hyderabad, Telangana, 502325.
Akron Formulations India Private Limited was incorporated on 05 August 1985.
The current directors of Akron Formulations India Private Limited are
The primary industry of Akron Formulations India Private Limited is Manufacturing.
Akron Formulations India Private Limited is unlisted.
The authorized capital of Akron Formulations India Private Limited is ₹14.00 Cr, and the paid-up capital is ₹13.98 Cr.
The compliance status of Akron Formulations India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX